Terrence C Kearney is Director of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 6,536 shares of VRTX, which is worth approximately $2.67 Million. The most recent transaction as insider was on Aug 10, 2023, when has been sold 10,000 shares (Common Stock) at a price of $350.0 per share, resulting in proceeds of $3,500,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.54K
0% 3M change
0% 12M change
Total Value Held $2.67 Million

Terrence C Kearney Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 10 2023
SELL
Open market or private sale
$3,500,000 $350.0 p/Share
10,000 Reduced 60.47%
6,536 Common Stock
Aug 10 2023
BUY
Exercise of conversion of derivative security
$1,275,400 $127.54 p/Share
10,000 Added 37.68%
16,536 Common Stock
May 01 2022
BUY
Grant, award, or other acquisition
-
725 Added 9.98%
6,536 Common Stock

Also insider at

XLRN
ACCELERON PHARMA INC Healthcare
TCK

Terrence C Kearney

Director
Boston, MA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX